{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-049499","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2026-07-24T12:31:43+00:00","discovered_at":"2026-07-24T12:35:02.328752+00:00","generated_at":"2026-07-24T12:35:07.006069+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vir Bio CFO Jason O'Byrne to step down; Brent Sabatini named interim principal financial officer","bullets":["CFO Jason O'Byrne resigns effective August 3, 2026, to pursue another opportunity; no disagreement with company.","Board appoints Brent Sabatini, SVP and CAO, as interim principal financial officer effective same date.","Sabatini has been CAO since Oct 2024, previously at Capsida and Amgen; no additional compensation for interim role.","Search for permanent CFO initiated."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-049499","json":"https://secwatch.observer/filing/0001628280-26-049499.json","markdown":"https://secwatch.observer/filing/0001628280-26-049499.md","text":"https://secwatch.observer/filing/0001628280-26-049499.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026049499/0001628280-26-049499-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026049499/vir-20260720.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T12:35:07.006069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}